Virginia Commonwealth University
Richmond, Virginia, 23298, United States
NCT Number: NCT06860698
The study is focused on investigating the mechanisms involved in microvascular health in subjects that use e-cigarettes frequently. To explore microvascular health, different techniques and compounds. For one of the tests, iontophoresis, the drug's use will be stored and handled as described by the approved IND and non-IDS plan.
Looking for future studies?
Notify MeElectronic cigarettes or e-cigarettes have become increasingly popular, due to their promotion as a healthy alternative to traditional tobacco cigarettes. However, there are large discrepancies of knowledge in understanding how these e-cigarettes affect the subjects health and the way their body uses oxygen. The overall goal of this study is to evaluate e-cigarettes usage on subjects health.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
e-Cig users arm
Inclusion criteria
Exclusion criteria
Non e-Cig using arm
Inclusion
Exclusion
Based on e-cigarette usage, participants will be divided into those who used e-cigarettes and those who did not use e-cigarettes
Time frame: Participation is one week
Endothelial-dependent dilation will be assessed using laser doppler speckle contrast in both groups through the intervention
Time frame: Participation is one week
Neurogenic response will be assessed using axon reflex in both groups through the intervention
Virginia Commonwealth University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05869318
Behavior, E-Cig Use
Columbus, Ohio, United States
View Trial DetailsNCT04854616
Behavior, Disease Attributes
Norwich, Norfolk, United Kingdom
View Trial DetailsNCT05932693
Behavior, E-Cig Use
New Haven, Connecticut, United States
View Trial DetailsNCT05432830
Behavior, Chemically-Induced Disorders
New Haven, Connecticut, United States
View Trial Details